A single virtual talk after a traumatic birth may ease lasting emotional distress

NCT ID NCT07684521

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This study tests whether a virtual debriefing session with a maternal-fetal medicine specialist, held six to eight weeks after a delivery complicated by severe maternal morbidity (such as ICU admission or major blood transfusion), can lower symptoms of post-traumatic stress, depression, and anxiety. Participants are randomly assigned to receive the debriefing at six weeks (control) or at twelve weeks (intervention), and all complete standard mental health questionnaires. The goal is to see if this simple, supportive conversation helps mothers emotionally recover after a frightening birth experience.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Virtual maternal fetal medicine debriefing consult
What this could lead to
If effective, this simple talk-based intervention could become a standard way to help new mothers recover emotionally after a traumatic delivery.
What could go wrong
This is a small, early-stage trial with only 52 participants, so results may not apply widely. The benefit of a single debriefing session may be limited.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANXIETY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Cedars Sinai Medical Center

    Los Angeles, California, 90048, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.